Patent ID: 7122380
Filing Date: 2006-10-17
Classification: A61K,A61P,G01N

Abstract:
1. A pharmaceutical composition suitable for administration to a human patient for mitigating a disease condition that is characterized by the pathological production of at least one specie of specific antibody by the patient, said disease being systemic lupus erythematosus, wherein said composition comprises: an immune complex of an antigen and purified antibody specific thereto, said antigen being selected from the group consisting of antigens that are targeted by antibodies in immunologic reactions characteristic of said autoimmune disease, said purified antibody comprising at least one specie of specific antibody that is essentially identical to said at least one specie of specific antibody pathologically produced by the patient, and said antigen and said purified antibody being present in a ratio such that said purified antibody blocks essentially all binding sites of said antigen; and a pharmacologically acceptable carrier or diluent.